Abstract
Plant viruses have recently come to the fore within the nanomedicine field. The advantages of these protein-based nanoparticles for use in medical applications include their inherent ability to withstand harsh environments, making them amendable for functionalization and formulation, their biocompatibility and biodegradability, their inherent ability to self-assemble into structurally uniform particles as well as being non-infectious and incapable of replicating in mammalian cells. Due to their proteinaceous nature, plant viral nanoparticles (VNPs) can be modified, and foreign cargo can be encapsulated within the capsid or attached to their interior or exterior capsid surfaces. The various cargo-loading processes used to tailor plant VNPs for biomedical applications include cargo infusion or caging, and genetic and chemical engineering of the VNPs allows for the display of targeting ligands/molecules, functional handles, antibodies, antigenic structures, proteins and small molecule drugs, amongst others. The morphology of plant VNPs can also be manipulated to change a particle’s properties to meet the requirements of a specific application. Bioengineered plant VNPs are being employed for the targeted delivery of drugs, nucleic acids, enzymes and proteins/peptides, immunotherapy and vaccines, and agents for medical imaging and therapeutics, all medical applications that will be discussed here.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Ala:
-
Alanine
- Asp:
-
Aspartic acid
- CCMV:
-
Cowpea chlorotic mottle virus
- CMV:
-
Cucumber mosaic virus
- CPA:
-
Cyclophosphamide
- CPMV:
-
Cowpea mosaic virus
- CT:
-
Computed tomography
- CYP:
-
Cytochrome P450
- Cys:
-
Cysteine
- DOX:
-
Doxorubicin
- E7p72:
-
Epidermal growth factor-like domain 7
- Gd:
-
Gadolinium
- GFP:
-
Green fluorescent protein
- Glu:
-
Glutamic acid
- Gly:
-
Glycine
- HER2:
-
Human epidermal growth factor receptor 2
- HSV-1-TK:
-
Herpes simplex virus 1 thymidine kinase
- Lys:
-
Lysine
- MRI:
-
Magnetic resonance imaging
- mRNA:
-
Messenger ribonucleic acid
- MTO:
-
Mitoxantrone
- NIR:
-
Near infra-red
- NPs:
-
Nanoparticles
- NY-ESO-1:
-
Cancer testis antigen
- ODNs:
-
Oligodeoxynucleotides
- PapMV:
-
Papaya mosaic virus
- PDA:
-
Polydopamine
- PDT:
-
Photodynamic therapy
- PEG:
-
Polyethylene glycol
- PET:
-
Positron emission tomography
- PhMV:
-
Physalis mottle virus particles
- PTT:
-
Photothermal therapy
- PVX:
-
Potato virus X
- RCNMV:
-
Red clover necrotic mosaic virus
- RNA:
-
Ribonucleic acid
- ROS:
-
Reactive oxygen species
- SEMV:
-
Sesbania mosaic virus
- siRNA:
-
Small interfering ribonucleic acid
- SrtA:
-
Sortase A
- TAA’s:
-
Tumor-associated antigens
- TACA’s:
-
Tumor-associated carbohydrate antigens
- TAT:
-
Transacting activation transduction
- TLR:
-
Toll-like receptor
- TME:
-
Tumor microenvironment
- TMV:
-
Tobacco mosaic virus
- TNF:
-
Tumor necrosis factor
- tPA:
-
Tissue plasminogen activator
- TRAIL:
-
Tumor necrosis factor (TNF) related apoptosis inducing ligand
- Trp:
-
Tryptophan
- Tyr:
-
Tyrosine
- vcMMAE:
-
Valine-citrulline monomethyl auristatin E
- VLP:
-
Virus-like particle
- VNPs:
-
Virus nanoparticles
References
Alemzadeh E, Dehshahri A, Izadpanah K, Ahmadi F (2018) Plant virus nanoparticles: novel and robust nanocarriers for drug delivery and imaging. Colloids Surf B Biointerfaces 167:20–27. https://doi.org/10.1016/j.colsurfb.2018.03.026
Alemzadeh E, Dehshahri A, Dehghanian AR, Afsharifar A, Behjatnia AA, Izadpanah K, Ahmadi F (2019) Enhanced antitumor efficacy and reduced cardiotoxicity of doxorubicin delivered in a novel plant virus nanoparticle. Colloids Surf B Biointerfaces 174:80–86. https://doi.org/10.1016/j.colsurfb.2018.11.008
Aljabali AAA, Zoubi MSA, Al-Batanyeh KM, Al-Radaideh A, Obeid MA, Al Sharabi A, Alshaer W, AbuFares B, Al-Zanati T, Tambuwala MM, Akbar N, Evans DJ (2019) Gold-coated plant virus as computed tomography imaging contrast agent. Beilstein J Nanotechnol 10(1):1983–1993. https://doi.org/10.3762/bjnano.10.195
Atabekov J, Nikitin N, Arkhipenko M, Chirkov S, Karpova O (2011) Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles. J Gen Virol 92(Pt 2):453–456. https://doi.org/10.1099/vir.0.024356-0
Azizgolshani O, Garmann RF, Cadena-Nava R, Knobler CM, Gelbart WM (2013) Reconstituted plant viral capsids can release genes to mammalian cells. Virology 441(1):12–17. https://doi.org/10.1016/j.virol.2013.03.001
Bakhshinejad B (2015) Phage display and targeting peptides: surface functionalization of nanocarriers for delivery of small non-coding RNAs. Front Genet 6:178. https://doi.org/10.3389/fgene.2015.00178
Balke I, Zeltins A (2019) Use of plant viruses and virus-like particles for the creation of novel vaccines. Adv Drug Deliv Rev 145:119–129. https://doi.org/10.1016/j.addr.2018.08.007
Biddlecome A, Habte HH, McGrath KM, Sambanthamoorthy S, Wurm M, Sykora MM, Knobler CM, Lorenz IC, Lasaro M, Elbers K, Gelbart WM (2019) Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles. PLoS One 14(6):e0215031. https://doi.org/10.1371/journal.pone.0215031
Bludau H, Czapar AE, Pitek AS, Shukla S, Jordan R, Steinmetz NF (2017) Poxylation as an alternative stealth coating for biomedical applications. Eur Polym J 88:679–688. https://doi.org/10.1016/j.eurpolymj.2016.10.041
Brasch M, de la Escosura A, Ma Y, Uetrecht C, Heck AJR, Torres T, Cornelissen JJLM (2011) Encapsulation of phthalocyanine supramolecular stacks into virus-like particles. J Am Chem Soc 133(18):6878–6881. https://doi.org/10.1021/ja110752u
Bruckman MA, Kaur G, Lee LA, **e F, Sepulveda J, Breitenkamp R, Zhang X, Joralemon M, Russell TP, Emrick T, Wang Q (2008) Surface modification of tobacco mosaic virus with “click” chemistry. Chembiochem 9(4):519–523. https://doi.org/10.1002/cbic.200700559
Bruckman MA, Randolph LN, VanMeter A, Hern S, Shoffstall AJ, Taurog RE, Steinmetz NF (2013) Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology 449:163–173. https://doi.org/10.1016/j.virol.2013.10.035
Bruckman MA, Jiang K, Simpson EJ, Randolph LN, Luyt LG, Yu X, Steinmetz NF (2014) Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus. Nano Lett 14(3):1551–1558. https://doi.org/10.1021/nl404816m
Bruckman MA, VanMeter A, Steinmetz NF (2015) Nanomanufacturing of tobacco mosaic virus-based spherical biomaterials using a continuous flow method. ACS Biomater Sci Eng 1(1):13–18. https://doi.org/10.1021/ab500059s
Bruckman MA, Czapar AE, VanMeter A, Randolph LN, Steinmetz NF (2016) Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer. J Control Release 231:103–113. https://doi.org/10.1016/j.jconrel.2016.02.045
Cai H, Shukla S, Wang C, Masarapu H, Steinmetz NF (2019a) Heterologous prime-boost enhances the antitumor immune response elicited by plant-virus-based cancer vaccine. J Am Chem Soc 141(16):6509–6518. https://doi.org/10.1021/jacs.9b01523
Cai H, Wang C, Shukla S, Steinmetz NF (2019b) Cowpea mosaic virus immunotherapy combined with cyclophosphamide reduces breast cancer tumor burden and inhibits lung metastasis. Adv Sci 6(16):1802281. https://doi.org/10.1002/advs.201802281
Cai H, Shukla S, Steinmetz NF (2020) The antitumor efficacy of CpG oligonucleotides is improved by encapsulation in plant virus-like particles. Adv Funct Mater 30(15):1908743. https://doi.org/10.1002/adfm.201908743
Campos SK, Barry MA (2007) Current advances and future challenges in adenoviral vector biology and targeting. Curr Gene Ther 7(3):189–204. https://doi.org/10.2174/156652307780859062
Cao J, Guenther RH, Sit TL, Opperman CH, Lommel SA, Willoughby JA (2014) Loading and release mechanism of red clover necrotic mosaic virus derived plant viral nanoparticles for drug delivery of doxorubicin. Small 10(24):5126–5136. https://doi.org/10.1002/smll.201400558
Cardinale D, Carette N, Michon T (2012) Virus scaffolds as enzyme nano-carriers. Trends Biotechnol 30(7):369–376. https://doi.org/10.1016/j.tibtech.2012.04.001
Chapman S, Faulkner C, Kaiserli E, Garcia-Mata C, Savenkov EI, Roberts AG, Oparka KJ, Christie JM (2008) The photoreversible fluorescent protein iLOV outperforms GFP as a reporter of plant virus infection. Proc Natl Acad Sci 105(50):20038–20043. https://doi.org/10.1073/pnas.0807551105
Chariou PL, Wang L, Desai C, Park J, Robbins LK, Recum HA, Ghiladi RA, Steinmetz NF (2019) Let there be light: targeted photodynamic therapy using high aspect ratio plant viral nanoparticles. Macromol Biosci 19(5):e1800407. https://doi.org/10.1002/mabi.201800407
Chariou PL, Ortega-Rivera OA, Steinmetz NF (2020) Nanocarriers for the delivery of medical, veterinary, and agricultural active ingredients. ACS Nano 14(3):2678–2701. https://doi.org/10.1021/acsnano.0c00173
Chen D, Wu Y, Zhang W, Jiang S, Chen S (2016) Horizontal gene transfer events reshape the global landscape of arm race between viruses and homo sapiens. Sci Rep 6(1):26934. https://doi.org/10.1038/srep26934
Cho C, Yu L, Nsiama TK, Kadam AN, Raturi A, Shukla S, Amadei GA, Steinmetz NF, Luyt LG, Lewis JD (2017) Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature. Nanoscale 9(33):12096–12109. https://doi.org/10.1039/C7NR02558K
Chung YH, Cai H, Steinmetz NF (2020) Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Adv Drug Deliv Rev 156:214–235. https://doi.org/10.1016/j.addr.2020.06.024
Colombo M, Mazzucchelli S, Montenegro JM, Galbiati E, Corsi F, Parak WJ, Prosperi D (2012) Protein oriented ligation on nanoparticles exploiting O6-alkylguanine-DNA transferase (SNAP) genetically encoded fusion. Small 8(10):1492–1497. https://doi.org/10.1002/smll.201102284
Czapar AE, Steinmetz NF (2017) Plant viruses and bacteriophages for drug delivery in medicine and biotechnology. Curr Opin Chem Biol 38:108–116. https://doi.org/10.1016/j.cbpa.2017.03.013
Czapar AE, Zheng Y, Riddell IA, Shukla S, Awuah SG, Lippard SJ, Steinmetz NF (2016) Tobacco mosaic virus delivery of phenanthriplatin for cancer therapy. ACS Nano 10(4):4119–4126. https://doi.org/10.1021/acsnano.5b07360
Czapar AE, Tiu BDB, Veliz FA, Pokorski JK, Steinmetz NF (2018) Slow-release formulation of cowpea mosaic virus for in situ vaccine delivery to treat ovarian cancer. Adv Sci 5(5):1700991. https://doi.org/10.1002/advs.201700991
Eiben S, Koch C, Altintoprak K, Southan A, Tovar G, Laschat S, Weiss IM, Wege C (2019) Plant virus-based materials for biomedical applications: trends and prospects. Adv Drug Deliv Rev 145:96–118. https://doi.org/10.1016/j.addr.2018.08.011
Erturk SM, Johnston C, Tempany-Afdhal C, Van den Abbeele AD (2009) Imaging tools in human research. In: Robertson D, Williams GH (eds) Clinical and translational science: principles of human research. Academic Press, London, pp 87–104. https://doi.org/10.1016/B978-0-12-373639-0.00006-6
Franke CE, Czapar AE, Patel RB, Steinmetz NF (2018) Tobacco mosaic virus-delivered cisplatin restores efficacy in platinum-resistant ovarian cancer cells. Mol Pharm 15(8):2922–2931. https://doi.org/10.1021/acs.molpharmaceut.7b00466
Gajewski TF, Schreiber H, Fu Y (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14(10):1014–1022. https://doi.org/10.1038/ni.2703
Hoopes PJ, Wagner RJ, Duval K, Kang K, Gladstone DJ, Moodie KL, Crary-Burney M, Ariaspulido H, Veliz FA, Steinmetz NF, Fiering SN (2018) Treatment of canine oral melanoma with nanotechnology-based immunotherapy and radiation. Mol Pharm 15(9):3717–3722. https://doi.org/10.1021/acs.molpharmaceut.8b00126
Hovlid ML, Steinmetz NF, Laufer B, Lau JL, Kuzelka J, Wang Q, Hyypiä T, Nemerow GR, Kessler H, Manchester M, Finn MG (2012) Guiding plant virus particles to integrin-displaying cells. Nanoscale 4(12):3698–3705. https://doi.org/10.1039/c2nr30571b
Hu H, Steinmetz NF (2020) Doxorubicin-loaded Physalis mottle virus particles function as a pH-responsive prodrug enabling cancer therapy. Biotechnol J 15(12):e2000077. https://doi.org/10.1002/biot.202000077
Hu Q, Sun W, Wang C, Gu Z (2016) Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev 98:19–34. https://doi.org/10.1016/j.addr.2015.10.022
Hu H, Zhang Y, Shukla S, Gu Y, Yu X, Steinmetz NF (2017) Dysprosium-modified tobacco mosaic virus nanoparticles for ultra-high-field magnetic resonance and near-infrared fluorescence imaging of prostate cancer. ACS Nano 11(9):9249–9258. https://doi.org/10.1021/acsnano.7b04472
Hu H, Masarapu H, Gu Y, Zhang Y, Yu X, Steinmetz NF (2019a) Physalis mottle virus-like nanoparticles for targeted cancer imaging. ACS Appl Mater Interfaces 11(20):18213–18223. https://doi.org/10.1021/acsami.9b03956
Hu H, Yang Q, Baroni S, Yang H, Aime S, Steinmetz NF (2019b) Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy. Nanoscale 11(19):976–9768. https://doi.org/10.1039/c9nr02065a
Ionita MG, van den Borne P, Catanzariti LM, Moll FL, de Vries JPM, Pasterkamp G, Vink A, de Kleijn DPV (2010) High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol 30(9):1842–1848. https://doi.org/10.1161/ATVBAHA.110.209296
Jeevanandam J, Pal K, Danquah MK (2019) Virus-like nanoparticles as a novel delivery tool in gene therapy. Biochimie 157:38–47. https://doi.org/10.1016/j.biochi.2018.11.001
Jobsri J, Allen A, Rajagopal D, Shipton M, Kanyuka K, Lomonossoff GP, Ottensmeier C, Diebold SS, Stevenson FK, Savelyeva N (2015) Plant virus particles carrying tumour antigen activate TLR7 and induce high levels of protective antibody. PLoS One 10(2):e0118096. https://doi.org/10.1371/journal.pone.0118096
Keeler AM, Flotte TR (2019) Recombinant adeno-associated virus gene therapy in light of luxturna (and Zolgensma and Glybera): where are we, and how did we get here? Annu Rev Virol 6(1):601–621. https://doi.org/10.1146/annurev-virology-092818-015530
Kernan DL, Wen AM, Pitek AS, Steinmetz NF (2017) Featured article: delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles. Exp Biol Med 242(14):1405–1411. https://doi.org/10.1177/1535370217719222
Kerstetter-Fogle A, Shukla S, Wang C, Beiss V, Harris PLR, Sloan AE, Steinmetz NF (2019) Plant virus-like particle in situ vaccine for intracranial glioma immunotherapy. Cancers 11(4):515. https://doi.org/10.3390/cancers11040515
Koo M, Bendahmane M, Lettieri GA, Paoletti AD, Lane TE, Fitchen JH, Buchmeier MJ, Beachy RN (1999) Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci 96(14):7774–7779. https://doi.org/10.1073/pnas.96.14.7774
Koyani R, Pérez-Robles J, Cadena-Nava RD, Vazquez-Duhalt R (2017) Biomaterial-based nanoreactors, an alternative for enzyme delivery. Nanotechnol Rev (Berlin) 6(5):405–419. https://doi.org/10.1515/ntrev-2016-0071
Kreppel F, Kochanek S (2008) Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol Ther 16(1):16–29. https://doi.org/10.1038/sj.mt.6300321
Kushnir N, Streatfield SJ, Yusibov V (2012) Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31(1):58–83. https://doi.org/10.1016/j.vaccine.2012.10.083
Lam P, Steinmetz NF (2019) Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particles. Biomater Sci 7(8):3138–3142. https://doi.org/10.1039/c9bm00785g
Lam P, Lin RD, Steinmetz NF (2018) Delivery of mitoxantrone using a plant virus-based nanoparticle for the treatment of glioblastomas. J Mater Chem B Mater Biol Med 6(37):5888–5895. https://doi.org/10.1039/c8tb01191e
Le DHT, Lee KL, Shukla S, Commandeur U, Steinmetz NF (2017) Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy. Nanoscale 9(6):2348–2357. https://doi.org/10.1039/c6nr09099k
Le DHT, Commandeur U, Steinmetz NF (2019a) Presentation and delivery of tumor necrosis factor-related apoptosis-inducing ligand via elongated plant viral nanoparticle enhances antitumor efficacy. ACS Nano 13(2):2501–2510. https://doi.org/10.1021/acsnano.8b09462
Le DHT, Méndez-López E, Wang C, Commandeur U, Aranda MA, Steinmetz NF (2019b) Biodistribution of filamentous plant virus nanoparticles: pepino mosaic virus versus potato virus X. Biomacromolecules 20(1):469–477. https://doi.org/10.1021/acs.biomac.8b01365
Lebel M, Chartrand K, Tarrab E, Savard P, Leclerc D, Lamarre A (2016) Potentiating cancer immunotherapy using papaya mosaic virus-derived nanoparticles. Nano Lett 16(3):1826–1832. https://doi.org/10.1021/acs.nanolett.5b04877
Lebel M, Langlois M, Daudelin J, Tarrab E, Savard P, Leclerc D, Lamarre A (2017) Complement component 3 regulates IFN-alpha production by plasmacytoid dendritic cells following TLR7 activation by a plant virus-like nanoparticle. J Immunol (1950) 198(1):292–299. https://doi.org/10.4049/jimmunol.1601271
Lee KL, Hubbard LC, Hern S, Yildiz I, Gratzl M, Steinmetz NF (2013) Shape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinct. Biomater Sci 1(6):581–588. https://doi.org/10.1039/C3BM00191A
Lee EJ, Lee NK, Kim I (2016a) Bioengineered protein-based nanocage for drug delivery. Adv Drug Deliv Rev 106(Pt A):157–171. https://doi.org/10.1016/j.addr.2016.03.002
Lee KL, Carpenter BL, Wen AM, Ghiladi RA, Steinmetz NF (2016b) High aspect ratio nanotubes formed by tobacco mosaic virus for delivery of photodynamic agents targeting melanoma. ACS Biomater Sci Eng 2(5):838–844. https://doi.org/10.1021/acsbiomaterials.6b00061
Lee KL, Murray AA, Le DHT, Sheen MR, Shukla S, Commandeur U, Fiering S, Steinmetz NF (2017) Combination of plant virus nanoparticle-based in situ vaccination with chemotherapy potentiates antitumor response. Nano Lett 17(7):4019–4028. https://doi.org/10.1021/acs.nanolett.7b00107
Lin RD, Steinmetz NF (2018) Tobacco mosaic virus delivery of mitoxantrone for cancer therapy. Nanoscale 1(34):1637–16313. https://doi.org/10.1039/c8nr04142c
Liu Y, Tan J, Thomas A, Ou-Yang D, Muzykantov VR (2012) The shape of things to come: importance of design in nanotechnology for drug delivery. Ther Deliv 3(2):181–194. https://doi.org/10.4155/tde.11.156
Liu X, Liu B, Gao S, Wang Z, Tian Y, Wu M, Jiang S, Niu Z (2017) Glyco-decorated tobacco mosaic virus as a vector for cisplatin delivery. J Mater Chem B Mater Biol Med 5(11):2078–2085. https://doi.org/10.1039/c7tb00100b
Lizotte PH, Wen AM, Sheen MR, Fields J, Rojanasopondist P, Steinmetz NF, Fiering S (2016) In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. Nat Nanotechnol 11(3):295–303. https://doi.org/10.1038/nnano.2015.292
Lockney DM, Guenther RN, Loo L, Overton W, Antonelli R, Clark J, Hu M, Luft C, Lommel SA, Franzen S (2011) The red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle. Bioconjug Chem 22(1):67–73. https://doi.org/10.1021/bc100361z
Ma Y, Nolte RJM, Cornelissen JJLM (2012) Virus-based nanocarriers for drug delivery. Adv Drug Deliv Rev 64(9):811–825. https://doi.org/10.1016/j.addr.2012.01.005
Mateu MG (2011) Virus engineering: functionalization and stabilization. Protein Eng Des Sel 24(1–2):53–63. https://doi.org/10.1093/protein/gzq069
Miermont A, Barnhill H, Strable E, Lu X, Wall KA, Wang Q, Finn M, Huang X (2008) Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines. Chem 14(16):4939–4947. https://doi.org/10.1002/chem.200800203
Mohan K, Weiss GA (2016) Chemically modifying viruses for diverse applications. ACS Chem Biol 11(5):1167–1179. https://doi.org/10.1021/acschembio.6b00060
Mohsen MO, Gomes AC, Vogel M, Bachmann MF (2018) Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system. Vaccine 6(3):37. https://doi.org/10.3390/vaccines6030037
Murray AA, Wang C, Fiering S, Steinmetz NF (2018) In situ vaccination with cowpea vs tobacco mosaic virus against melanoma. Mol Pharm 15(9):3700–3716. https://doi.org/10.1021/acs.molpharmaceut.8b00316
Nikitin NA, Trifonova EA, Karpova OV, Atabekov JG (2016) Biosafety of plant viruses for human and animals. Mosc Univ Biol Sci Bull 71(3):128–134. https://doi.org/10.3103/S0096392516030081
Nkanga CI, Steinmetz NF (2021) The pharmacology of plant virus nanoparticles. Virology 556:39–61. https://doi.org/10.1016/j.virol.2021.01.012
Park J, Gao H, Wang Y, Hu H, Simon DI, Steinmetz NF (2019) S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE −/− mice. J Mater Chem B Mater for Biol Med 7(11):1842–1846. https://doi.org/10.1039/c8tb02276c
Park J, Chariou PL, Steinmetz NF (2020) Site-specific antibody conjugation strategy to functionalize virus-based nanoparticles. Bioconjug Chem 31(5):1408–1416. https://doi.org/10.1021/acs.bioconjchem.0c00118
Patel BK, Wang C, Lorens B, Levine AD, Steinmetz NF, Shukla S (2020) Cowpea mosaic virus (CPMV)-based cancer testis antigen NY-ESO-1 vaccine elicits an antigen-specific cytotoxic T cell response. ACS Appl Bio Mater 3(7):4179–4187. https://doi.org/10.1021/acsabm.0c00259
Pitek AS, Hu H, Shukla S, Steinmetz NF (2018a) Cancer theranostic applications of albumin-coated tobacco mosaic virus nanoparticles. ACS Appl Mater Interfaces 10(46):39468–39477. https://doi.org/10.1021/acsami.8b12499
Pitek AS, Park J, Wang Y, Gao H, Hu H, Simon DI, Steinmetz NF (2018b) Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage. Nanoscale 10(35):16547–16555. https://doi.org/10.1039/c8nr02861c
Pokorski JK, Steinmetz NF (2011) The art of engineering viral nanoparticles. Mol Pharm 8(1):29–43. https://doi.org/10.1021/mp100225y
Ratnatilaka Na Bhuket P, Luckanagul JA, Rojsitthisak P, Wang Q (2018) Chemical modification of enveloped viruses for biomedical applications. Integr Biol (Camb) 1(11):666–679. https://doi.org/10.1039/c8ib00118a
Ren Y, Wong SM, Lim L (2007) Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjug Chem 18(3):836–843. https://doi.org/10.1021/bc060361p
Sánchez-Sánchez L, Cadena-Nava RD, Palomares LA, Ruiz-Garcia J, Koay MST, Cornelissen JJMT, Vazquez-Duhalt R (2014) Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450. Enzym Microb Technol 60:24–31. https://doi.org/10.1016/j.enzmictec.2014.04.003
Schoonen L, Pille J, Borrmann A, Nolte RJM, van Hest JCM (2015) Sortase A-mediated N-terminal modification of cowpea chlorotic mottle virus for highly efficient cargo loading. Bioconjug Chem 26(12):2429–2434. https://doi.org/10.1021/acs.bioconjchem.5b00485
Schoonen L, Maassen S, Nolte RJM, van Hest JCM (2017) Stabilization of a virus-like particle and its application as a nanoreactor at physiological conditions. Biomacromolecules 18(11):3492–3497. https://doi.org/10.1021/acs.biomac.7b00640
Schwarz B, Douglas T (2015) Development of virus-like particles for diagnostic and prophylactic biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7(5):722–735. https://doi.org/10.1002/wnan.1336
Shanmugam V, Selvakumar S, Yeh C (2014) Near-infrared light-responsive nanomaterials in cancer therapeutics. Chem Soc Rev 43(17):6254–6287. https://doi.org/10.1039/c4cs00011k
Shoeb E, Hefferon K (2019) Future of cancer immunotherapy using plant virus-based nanoparticles. Fut Sci OA 5(7):FSO401. https://doi.org/10.2144/fsoa-2019-0001
Shukla S, Ablack AL, Wen AM, Lee KL, Lewis JD, Steinmetz NF (2013) Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle potato virus X. Mol Pharm 10(1):33–42. https://doi.org/10.1021/mp300240m
Shukla S, Dorand RD, Myers JT, Woods SE, Gulati NM, Stewart PL, Commandeur U, Huang AY, Steinmetz NF (2016a) Multiple administrations of viral nanoparticles alter in vivo behavior-insights from intravital microscopy. ACS Biomater Sci Eng 2(5):829–837. https://doi.org/10.1021/acsbiomaterials.6b00060
Shukla S, Myers JT, Woods SE, Gong X, Czapar AE, Commandeur U, Huang AY, Levine A, Steinmetz NF (2016b) Plant viral nanoparticles-based HER2 vaccine: immune response influenced by differential transport, localization and cellular interactions of particulate carriers. Biomaterials 121:15–27. https://doi.org/10.1016/j.biomaterials.2016.12.030
Shukla S, Dickmeis C, Fischer R, Commandeur U, Steinmetz NF (2018) In planta production of fluorescent filamentous plant virus-based nanoparticles. In: Methods in molecular biology (Clifton, N.J.). Springer, New York, pp 61–84. https://doi.org/10.1007/978-1-4939-7808-3_5
Shukla S, Jandzinski M, Wang C, Gong X, Bonk KW, Keri RA, Steinmetz NF (2019) A viral nanoparticle cancer vaccine delays tumor progression and prolongs survival in a HER2+ tumor mouse model. Adv Ther 2(4):1800139. https://doi.org/10.1002/adtp.201800139
Shukla S, Roe AJ, Liu R, Veliz FA, Commandeur U, Wald DN, Steinmetz NF (2020a) Affinity of plant viral nanoparticle potato virus X (PVX) towards malignant B cells enables cancer drug delivery. Biomater Sci 8(14):3935–3943. https://doi.org/10.1039/d0bm00683a
Shukla S, Wang C, Beiss V, Steinmetz NF (2020b) Antibody response against cowpea mosaic viral nanoparticles improves in situ vaccine efficacy in ovarian cancer. ACS Nano 14(3):2994–3003. https://doi.org/10.1021/acsnano.9b07865
Sokullu E, Soleymani Abyaneh H, Gauthier MA (2019) Plant/bacterial virus-based drug discovery, drug delivery, and therapeutics. Pharmaceutics 11(5):211. https://doi.org/10.3390/pharmaceutics11050211
Song C, Phuengkham H, Kim YS, Dinh VV, Lee I, Shin IW, Shin HS, ** SM, Um SH, Lee H, Hong KS, ** S, Lee E, Kang TH, Park Y, Lim YT (2019) Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence. Nat Commun 10(1):3745–3715. https://doi.org/10.1038/s41467-019-11730-8
Srivastava AS, Kaido T, Carrier E (2004) Immunological factors that affect the in vivo fate of T7 phage in the mouse. J Virol Methods 115(1):99–104. https://doi.org/10.1016/j.jviromet.2003.09.009
Steele JFC, Peyret H, Saunders K, Castells-Graells R, Marsian J, Meshcheriakova Y, Lomonossoff GP (2017) Synthetic plant virology for nanobiotechnology and nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(4):e1447. https://doi.org/10.1002/wnan.1447
Steinmetz NF (2010) Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 6(5):634–641. https://doi.org/10.1016/j.nano.2010.04.005
Steinmetz NF, Manchester M (2009) PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo. Biomacromolecules 10(4):784–792. https://doi.org/10.1021/bm8012742
Strable E, Finn MG (2009) Chemical modification of viruses and virus-like particles. In: Current topics in microbiology and immunology. Springer, Berlin, pp 1–21. https://doi.org/10.1007/978-3-540-69379-6_1
Suci PA, Varpness Z, Gillitzer E, Douglas T, Young M (2007) Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. Langmuir 23(24):12280–12286. https://doi.org/10.1021/la7021424
Thérien A, Bédard M, Carignan D, Rioux G, Gauthier-Landry L, Laliberté-Gagné M, Bolduc M, Savard P, Leclerc D (2017) A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling. J Nanobiotechnol 15(1):54. https://doi.org/10.1186/s12951-017-0289-y
Thuenemann EC, Le DHT, Lomonossoff GP, Steinmetz NF (2021) Bluetongue virus particles as nanoreactors for enzyme delivery and cancer therapy. Mol Pharm 18(3):1150–1156. https://doi.org/10.1021/acs.molpharmaceut.0c01053
Tian Y, Zhou M, Shi H, Gao S, **e G, Zhu M, Wu M, Chen J, Niu Z (2018) Integration of cell-penetrating peptides with rod-like bionanoparticles: virus-inspired gene-silencing technology. Nano Lett 18(9):5453–5460. https://doi.org/10.1021/acs.nanolett.8b01805
Unzueta U, Céspedes MV, Vázquez E, Ferrer-Miralles N, Mangues R, Villaverde A (2015) Towards protein-based viral mimetics for cancer therapies. Trends Biotechnol 33(5):253–258. https://doi.org/10.1016/j.tibtech.2015.02.007
Vernekar AA, Berger G, Czapar AE, Veliz FA, Wang DI, Steinmetz NF, Lippard SJ (2018) Speciation of phenanthriplatin and its analogs in the core of tobacco mosaic virus. J Am Chem Soc 140(12):4279–4287. https://doi.org/10.1021/jacs.7b12697
Wang C, Steinmetz NF (2019) CD47 blockade and cowpea mosaic virus nanoparticle in situ vaccination triggers phagocytosis and tumor killing. Adv Healthc Mater 8(8):e1801288. https://doi.org/10.1002/adhm.201801288
Wang C, Fiering SN, Steinmetz NF (2019) Cowpea mosaic virus promotes antitumor activity and immune memory in a mouse ovarian tumor model. Adv Ther 2(5):1900003. https://doi.org/10.1002/adtp.201900003
Wen AM, Steinmetz NF (2016) Design of virus-based nanomaterials for medicine, biotechnology and energy. Chem Soc Rev 45:4074–4126. https://doi.org/10.1039/c5cs00287g
Wen AM, Infusino M, De Luca A, Kernan DL, Czapar AE, Strangi G, Steinmetz NF (2015a) Interface of physics and biology: engineering virus-based nanoparticles for biophotonics. Bioconjug Chem 26(1):51–62. https://doi.org/10.1021/bc500524f
Wen AM, Wang Y, Jiang K, Hsu GC, Gao H, Lee KL, Yang AC, Yu X, Simon DI, Steinmetz NF (2015b) Sha** bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging. J Mater Chem B Mater Biol Med 3(29):6037–6045. https://doi.org/10.1039/C5TB00879D
Wu M, Shi J, Fan D, Zhou Q, Wang F, Niu Z, Huang Y (2013) Biobehavior in normal and tumor-bearing mice of tobacco mosaic virus. Biomacromolecules 14(11):4032–4037. https://doi.org/10.1021/bm401129j
Yildiz I, Lee KL, Chen K, Shukla S, Steinmetz NF (2013) Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery. J Control Release 172(2):568–578. https://doi.org/10.1016/j.jconrel.2013.04.023
Yin Z, Nguyen HG, Chowdhury S, Bentley P, Bruckman MA, Miermont A, Gildersleeve JC, Wang Q, Huang X (2012) Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens. Bioconjug Chem 23(8):1694–1703. https://doi.org/10.1021/bc300244a
Zeng Q, Wen H, Wen Q, Chen X, Wang Y, Xuan W, Liang J, Wan S (2013) Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Biomaterials 34(19):4632–4642. https://doi.org/10.1016/j.biomaterials.2013.03.017
Zhao L, Kopylov M, Potter CS, Carragher B, Finn MG (2019) Engineering the PP7 virus capsid as a peptide display platform. ACS Nano 13(4):4443–4454. https://doi.org/10.1021/acsnano.8b09683
Zhou Y, Maharaj PD, Mallajosyula JK, McCormick AA, Kearney CM (2014) In planta production of flock house virus transencapsidated RNA and its potential use as a vaccine. Mol Biotechnol 57(4):325–336. https://doi.org/10.1007/s12033-014-9826-1
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Rutkowska, D.A. (2024). Medical Applications of Plant Virus Nanoparticles. In: Kole, C., Chaurasia, A., Hefferon, K.L., Panigrahi, J. (eds) Applications of Plant Molecular Farming. Concepts and Strategies in Plant Sciences. Springer, Singapore. https://doi.org/10.1007/978-981-97-0176-6_15
Download citation
DOI: https://doi.org/10.1007/978-981-97-0176-6_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-97-0175-9
Online ISBN: 978-981-97-0176-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)